Follow the 대한약품 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 대한약품 has logged 138 reports. The latest transaction was disclosed on 9 July 2026 (Other). Among the most active insiders: 이윤우. The full history is accessible without an account.
138
Insider Decl.
0
Thresholds
€15,521
40 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Buys €15,521· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
대한약품 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the manufacturing of pharmaceutical products and medications.